Clinical Trial Update: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study evaluating gemcitabine plus oxaliplatin as second-line therapy for stage III or IV non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Miami | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED